Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1216541.RABb0qVPlbvAQz7OBYfcTcablNuGYvuRwR5Dd3m_3hZew130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1216541.RABb0qVPlbvAQz7OBYfcTcablNuGYvuRwR5Dd3m_3hZew130_assertion type Assertion NP1216541.RABb0qVPlbvAQz7OBYfcTcablNuGYvuRwR5Dd3m_3hZew130_head.
- NP1216541.RABb0qVPlbvAQz7OBYfcTcablNuGYvuRwR5Dd3m_3hZew130_assertion description "[Here, we explore limitations of using Mendelian randomization to evaluate CHD risk, including potential confounding by the widespread use of statin therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1216541.RABb0qVPlbvAQz7OBYfcTcablNuGYvuRwR5Dd3m_3hZew130_provenance.
- NP1216541.RABb0qVPlbvAQz7OBYfcTcablNuGYvuRwR5Dd3m_3hZew130_assertion evidence source_evidence_literature NP1216541.RABb0qVPlbvAQz7OBYfcTcablNuGYvuRwR5Dd3m_3hZew130_provenance.
- NP1216541.RABb0qVPlbvAQz7OBYfcTcablNuGYvuRwR5Dd3m_3hZew130_assertion SIO_000772 25185943 NP1216541.RABb0qVPlbvAQz7OBYfcTcablNuGYvuRwR5Dd3m_3hZew130_provenance.
- NP1216541.RABb0qVPlbvAQz7OBYfcTcablNuGYvuRwR5Dd3m_3hZew130_assertion wasDerivedFrom befree-2016 NP1216541.RABb0qVPlbvAQz7OBYfcTcablNuGYvuRwR5Dd3m_3hZew130_provenance.
- NP1216541.RABb0qVPlbvAQz7OBYfcTcablNuGYvuRwR5Dd3m_3hZew130_assertion wasGeneratedBy ECO_0000203 NP1216541.RABb0qVPlbvAQz7OBYfcTcablNuGYvuRwR5Dd3m_3hZew130_provenance.